Silver Sponsor

The Bioclinica Research Network simplifies the complexity and solves the challenges associated with vaccine clinical trials. Whatever stage your vaccine research is in (Phase I-IV), Bioclinica can assist with a global network of established, readily-available investigator sites and extensive patient recruitment capabilities. Bioclinica research sites operate in 14 countries across four continents: Europe, North America, South America, and Asia, with a dedicated SMO service in China that is focused on delivery of qualified patients. The Bioclinica Research Network rises above vaccine recruitment challenges to find the patients you want at the speed you need.